Modus Therapeutics Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 123.2%.

Top 12 shareholders own 34.9% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17%	Karolinska Development AB (publ)	6,104,821	kr6.1m	0%	7.44%
7.66%	KDev Investments AB	2,752,516	kr2.8m	0%	no data
4.82%	John Öhd	1,730,591	kr1.7m	0%	no data
1.76%	Hans Wigzell	632,392	kr635.6k	0%	no data
0.97%	Anders Bladh	348,000	kr349.7k	0%	no data
0.73%	Nordnet AB (publ), Asset Management Arm	260,625	kr261.9k	0%	no data
0.54%	Ellen Donnelly	195,073	kr196.0k	0%	no data
0.53%	Avanza Fonder AB	189,154	kr190.1k	0%	no data
0.33%	Per Lindqvist	120,000	kr120.6k	0%	no data
0.28%	Bo Hederstedt	100,000	kr100.5k	0%	no data
0.28%	Pauli Hammer	100,000	kr100.5k	0%	no data
0.03%	Claes Lindblad	10,812	kr10.9k	0%	no data